Press Release Distribution
Pricing
Customer Support
(800) 998-2927
Login
Log In
All Categories
Business
Entertainment
Health
Finance
Other
Tagged
ampakines
Press Release
Feb 2, 2011
Cortex's Ampakine CX1739 Improves Respiratory Parameters in Obstructive Sleep Apnea Patients
The study demonstrated that selected oxygen saturation parameters were statistically improved by one dose of CX1739, but the interpretation of these results was complicated by a reduced sleep time during the night following drug treatment.
Read More
Press Release
Oct 6, 2010
Cortex Obtains Exclusive Worldwide Rights for the Combination of AMPAKINE® and mGluR5 Compounds for the Treatment of Fragile X
This broad method-of-use patent application covers the combined use of AMPAKINE compounds and metabotropic glutamate receptor type 5 (mGluR5) antagonists for the treatment of Fragile X syndrome.
Read More
Press Release
Jul 6, 2010
Cortex Receives Funding From The Michael J. Fox Foundation To Discover Drug Candidates For Parkinson's Disease
The award will be used to test Cortex's selected proprietary High Impact AMPAKINE drug candidates in the mouse MPTP model of Parkinson's disease (PD), a well-validated model that exhibits many of the hallmarks of human Parkinson's disease and h
Read More
First
Prev
1
Next
Last